PaxMedica Inc (NASDAQ: PXMD) stock fell -44.00% on Monday to $0.98 against a previous-day closing price of $1.75. With 4.32 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.05 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.1500 whereas the lowest price it dropped to was $0.9500. The 52-week range on PXMD shows that it touched its highest point at $69.19 and its lowest point at $1.65 during that stretch. Beta for the stock currently stands at 0.90.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PXMD was down-trending over the past week, with a drop of -42.69%, but this was down by -73.89% over a month. Three-month performance dropped to -89.78% while six-month performance fell -96.23%. The stock lost -96.28% in the past year, while it has lost -97.16% so far this year.

Float and Shares Shorts:

At present, 0.71 million PXMD shares are outstanding with a float of 0.33 million shares on hand for trading. On Oct 30, 2023, short shares totaled 43550.0, which was 4.30% higher than short shares on Sep 28, 2023. In addition to Mr. Howard J. Weisman as the firm’s CEO & Chairman, Mr. Stephen Douglas Sheldon serves as its CFO & COO.

Institutional Ownership:

Other institutions hold 1.23% of PXMD, in contrast to 0.50% held by mutual funds. As the largest shareholder in PXMD with 0.56% of the stake, Renaissance Technologies LLC holds 5,712 shares worth 5,712. A second-largest stockholder of PXMD, The Vanguard Group, Inc., holds 3,233 shares, controlling over 0.32% of the firm’s shares. Clearstead Advisors, LLC is the third largest shareholder in PXMD, holding 2,244 shares or 0.22% stake. With a 0.32% stake in PXMD, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 3,233 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.16% of PXMD stock, is the second-largest Mutual Fund holder. It holds 1,609 shares valued at 5068.0. Fidelity Nasdaq Composite Index F holds 0.02% of the stake in PXMD, owning 175 shares worth 551.0.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PXMD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Leave a Reply

Your email address will not be published. Required fields are marked *